All Stories

  1. New plots in the partnerships of contemporary STEMI care: Revival of the ‘ménage à trois’?
  2. Manual Cardiopulmonary Resuscitation Versus CPR Including a Mechanical Chest Compression Device in Out-of-Hospital Cardiac Arrest: A Comprehensive Meta-analysis From Randomized and Observational Studies
  3. Aneurysm of the Pulmonary Artery
  4. Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70years and older—rationale and design of the POPular AGE study
  5. Ventricular fibrillation waveform characteristics differ according to the presence of a previous myocardial infarction: A surface ECG study in ICD-patients
  6. Reducing cardiac after-load by lowering blood viscosity in patients with familial hypercholesterolemia – A pilot study. Possible mechanism for occurrence of anemia in chronic heart failure patients?
  7. Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial
  8. Tako-tsubo cardiomyopathy is age-dependent in men, but not in women
  9. STEMI or non-STEMI: that is the question
  10. Direct Drug-Eluting Stenting to Reduce Stent Restenosis
  11. Meta-Analysis of Time-Related Benefits of Statin Therapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
  12. Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients
  13. Myocardial perfusion imaging with a cadmium zinc telluride-based gamma camera versus invasive fractional flow reserve
  14. Angiography guided therapy in an all comer acute coronary syndrome patient population
  15. THE LEFT SUBCLAVIAN ARTERY AS PRIMARY ACCESS SITE FOR TRANSCATHETER AORTIC VALVE IMPLANTATION
  16. A clinical appraisal of different Z-score equations for aortic root assessment in the diagnostic evaluation of Marfan syndrome
  17. Electrocardiographic parameters in women ten years post-early preeclampsia
  18. Predictors and importance of prolonged hospital stay after primary PCI for ST elevation myocardial infarction
  19. AS10 AutoPulse facilitated resuscitation in out-of-hospital cardiac arrest as a brigde to coronary intervention
  20. Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay
  21. The Impact of Age on Effects of Pre-hospital Initiation of High Bolus Dose of Tirofiban Before Primary Angioplasty for ST-Elevation Myocardial Infarction
  22. DO STEMI PATIENTS WHO LIVE FURTHER AWAY FROM THE PCI CENTRE HAVE WORSE OUTCOME?
  23. CARDIOVASCULAR RISK FACTORS IN WOMEN 10 YEARS POST EARLY PREECLAMPSIA: BASELINE DATA FROM THE PREECLAMPSIA RISK EVALUATION IN FEMALES STUDY (PREVFEM)
  24. High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: Results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration
  25. Poor outcome after recurrent acute myocardial infarction: A plea for optimal secondary prevention
  26. Prehospital triage in the ambulance reduces infarct size and improves clinical outcome
  27. Impact of diabetes on outcome in patients with non-ST-elevation myocardial infarction
  28. RESPONSE TO DR. GUTIERREZ AND COLLEAGUES
  29. Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction
  30. Old Age and Outcome After Primary Angioplasty for Acute Myocardial Infarction
  31. Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?
  32. How to Organize Networks for Invasive Treatment of STEMI
  33. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction
  34. Comparison of Rapamycin- and Paclitaxel-Eluting Stents in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
  35. Primary percutaneous coronary intervention for ST-elevation myocardial infarction: From clinical trial to clinical practice
  36. AS-4: Routine Use of a New Endothelial Progenitor Cell Antibody-Coated Stent in Patients with Primary PCI for ST-Elevation Myocardial Infarction: A Prospective Registry
  37. AS-88: Primary Coronary Intervention for ST-Segment Elevation Myocardial Infarction in Indonesia: Comparison with Europe
  38. Routine stenting vs. balloon angioplasty in ST-segment elevation myocardial infarction due to proximal left anterior descending coronary artery occlusion
  39. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction
  40. Percutaneous Coronary Intervention With Off-Site Cardiac Surgical Backup
  41. Prognostic importance of creatine kinase and creatine kinase–MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction
  42. Comparison of Usefulness of C-reactive Protein Versus White Blood Cell Count to Predict Outcome After Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction
  43. Change of white blood cell count more prognostic important than baseline values after primary percutaneous coronary intervention for ST elevation myocardial infarction
  44. The importance of left ventricular function in long-term prognosis after primary percutaneous coronary intervention
  45. Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
  46. Mortality in Patients With Left Ventricular Ejection Fraction ≤30% After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
  47. Prognostic importance of troponin T and creatine kinase after elective angioplasty
  48. Comparison between stenting and balloon in elderly patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
  49. Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty
  50. Routine upstream versus selective down stream use of tirofiban in non-ST elevation myocardial infarction patients scheduled for early invasive therapy; a randomized comparison
  51. External validity of ST elevation myocardial infarction trials: The Zwolle studies
  52. Are patients with non-ST elevation myocardial infarction undertreated?
  53. Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary
  54. Comparison between stenting and balloon angioplasty in patients undergoing primary angioplasty of small coronary vessels
  55. Impact of statin therapy at discharge on 1-year mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty
  56. Treatment decisions in stable coronary artery disease: Insights from the Euro Heart Survey on Coronary Revascularization
  57. Implantable defibrillator early after primary percutaneous intervention for ST-elevation myocardial infarction: Rationale and design of the Defibrillator After Primary Angioplasty (DAPA) Trial
  58. Incidence and predictors of subacute thrombosis in patients undergoing primary angioplasty for an acute myocardial infarction
  59. Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction
  60. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction
  61. Impact of infarct location on left ventricular ejection fraction after correction for enzymatic infarct size in acute myocardial infarction treated with primary coronary intervention
  62. Feasibility and benefit of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction
  63. Impact of routine stenting on myocardial perfusion and the extent of myocardial necrosis in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
  64. Successful reperfusion for acute ST elevation myocardial infarction is associated with a decrease in WBC count
  65. Platelet microaggregation inhibition in patients with acute myocardial infarction pretreated with tirofiban and relationship with angiographic and clinical outcome
  66. Effect of Coronary Occlusion Site on Angiographic and Clinical Outcome in Acute Myocardial Infarction Patients Treated With Early Coronary Intervention
  67. Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention
  68. Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction
  69. Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
  70. Ventricular fibrillation in acute myocardial infarction before and during primary PCI
  71. Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplasty
  72. Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
  73. Impact of Beta-Blocker Therapy at Discharge on Long-Term Mortality After Primary Angioplasty for ST-Segment Elevation Myocardial Infarction
  74. Primary angioplasty versus prehospital thrombolysis: how do the treatment costs compare?
  75. ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion
  76. Relation of Interhospital Delay and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Transferred for Primary Coronary Angioplasty
  77. Absence of Seasonal Variation in Myocardial Perfusion, Enzymatic Infarct Size, and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Angioplasty
  78. Comparison of Myocardial Perfusion After Successful Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction With Versus Without Diabetes Mellitus
  79. Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
  80. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: Rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)
  81. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction
  82. Impact of ST-segment depression resolution on mortality after successful mechanical reperfusion in patients with ST-segment elevation acute myocardial infarction
  83. Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: Data from the Zwolle Myocardial Infarction study
  84. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction
  85. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction
  86. Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting
  87. Randomized comparison of balloon angioplasty versus silicon Carbon-Coated stent implantation for de novo lesions in small coronary arteries
  88. Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty
  89. 833-3 Statin therapy and mortality in patients with acute myocardial infarction treated with primary angioplasty
  90. 1154-86 Hyperglycaemia reduces myocardial reperfusion during primary percutaneous coronary intervention for ST-elevation myocardial infarction
  91. 1061-98 Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction and signs of heart failure
  92. 1081-57 Randomized comparison between stent and balloon in diabetic with ST-segment elevation myocardial infarction undergoing primary angioplasty: A substudy of the Zwolle-6 randomized trial
  93. 1001-4 Impact of initial patency of the infarct related vessel on outcome in patients with acute myocardial infarction treated with primary angioplasty
  94. Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: An angiographic risk score for use in the catheterization laboratory
  95. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty
  96. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction
  97. The prognostic importance of heart failure and age in patients treated with primary angioplasty
  98. Relationship between time-to-reperfusion and 30-day mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty
  99. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade
  100. Angiographic predictors of left ventricular ejection fraction after successful angioplasty in acute myocardial infarction: An angiographic risk score for use in the catheterization laboratory
  101. No mortality benefit of primary angioplasty over thrombolytic therapy in patients with nonanterior myocardial infarction at long-term follow-up: Results of the zwolle trial
  102. Impact of multivessel disease on recovery of left ventricular function after primary angioplasty for acute myocardial infarction
  103. Outcome in patients treated with primary angioplasty for acute myocardial infarction due to left main coronary artery occlusion
  104. Reperfusion therapy in elderly patients with acute myocardial infarction
  105. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction
  106. Angiographic determinants of infarct size after successful percutaneous intervention for acute ST-T elevation myocardial infarction: the impact of distal embolization
  107. Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction
  108. High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial
  109. Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction
  110. Improvement in three-month angiographic outcome suggested after primary angioplasty for acute myocardial infarction (Zwolle trial) compared with successful thrombolysis (APRICOT trial)
  111. Limitation of myocardial infarct size after primary angioplasty: Is a higher patency the only mechanism?
  112. Randomised comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
  113. Incidence and predictors of restenosis after successful primary coronary angioplasty for acute myocardial infarction: The importance of age and procedural result
  114. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty
  115. Costs of stenting for acute myocardial infarction
  116. Treating Myocardial Infarction in the Post-GUSTO Era
  117. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
  118. Randomized Comparison of Primary Coronary Angioplasty With Thrombolytic Therapy in Low Risk Patients With Acute Myocardial Infarction
  119. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction
  120. 778-3 Better Vessel Status with Less Reocclusion at 3 Months as Additional Mechanism for Improved Outcome of Primary Angioplasty for Acute Myocardial Infarction
  121. Correlation between clinical course and quantitative analysis of the ischemia related artery in patients with unstable angina pectoris, refractory to medical treatment
  122. Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction
  123. Coronary artery bypass grafting early after acute myocardial infarction in patients initially treated with thrombolytic therapy or coronary angioplasty
  124. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: Left ventricular ejection fraction, hospital mortality and reinfarction
  125. Clinical and quantitative angiographic results of a randomized trial comparing direct coronary angioplasty with intravenous streptokinase in acute myocardial infarction
  126. Evaluation of thrombolytic and monoclonal platelet GPIIb/IIIa receptor antibody therapy in refractory unstable angina pectoris: correlation between quantitative assessment of coronary angiograms and clinical course
  127. A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial Infarction
  128. Crossing failure in PTCA: Mind the deflated balloon profile!